Patent 7955620 was granted and assigned to Sun Pharmaceutical on June, 2011 by the United States Patent and Trademark Office.
The present invention provides a stable oral composition comprising a therapeutically effective amount of desloratadine and a stabilizer selected from the group comprising an antioxidant, a pharmaceutically acceptable organic compound that provides an alkaline pH, an alkali metal salt, or mixtures thereof, and pharmaceutically acceptable excipients.